FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/058892 [Registered on: 19/10/2023] Trial Registered Prospectively
Last Modified On: 17/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study of Gokshuradi Guggulu prepared with two types in patients of urinary tract infection( mutrakriccha) 
Scientific Title of Study   A comparative pharmaceutico analytical & clinical study of Gokshuradi Guggulu prepared with two types of Guggulu shodhana & its effect on Mutrakriccha w.s.r. to UTI  
Trial Acronym  NA 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rohit Parmar 
Designation  MD Scholar 
Affiliation  Post graduate training and research institute Government Ayurvedic College, Patiala  
Address  PG Department of Rasa shastra and bhaishajya kalpana, Post graduate training and research institute Government Ayurvedic College, Patiala PUNJAB 147001 India

Patiala
PUNJAB
147001
India 
Phone  9754394006  
Fax    
Email  rohitparmar044@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abhishek 
Designation  Lecturer 
Affiliation  Post graduate training and research institute Government Ayurvedic College, Patiala 
Address  PG Department of Rasa shastra and bhaishajya kalpana, Post graduate training and research institute Government Ayurvedic College, Patiala

Patiala
PUNJAB
147001
India 
Phone  8310409168  
Fax    
Email  abhi.gehlot04@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Abhishek 
Designation  Lecturer 
Affiliation  Post graduate training and research institute Government Ayurvedic College, Patiala 
Address  PG Department of Rasa shastra and bhaishajya kalpana, Post graduate training and research institute Government Ayurvedic College, Patiala

Patiala
PUNJAB
147001
India 
Phone  8310409168  
Fax    
Email  abhi.gehlot04@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurvedic College Patiala punjab 
 
Primary Sponsor  
Name  Government Ayurvedic College 
Address  Government Ayurvedic College, Patiala, Punjab 147001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rohit Parmar  Government Ayurvedic Hospital, Patiala, Punjab  Room no. 16, Ground floor Department of Shalya tantra, Government Ayurvedic Hospital, Patiala, Punjab, 147001
Patiala
PUNJAB 
9754394006

rohitparmar044@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Govrnment Ayurvedic College, Ptaiala, Punjab, no. 4680  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gokshuradi guggulu, Reference: sharangdhara samhita, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: sukhushna jala), Additional Information: in this, guggulu shodhana is done with guduchi kwatha
2Comparator ArmDrugClassical(1) Medicine Name: Gokshuradi guggulu , Reference: sharangdhara samhita, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: sukhushna jala), Additional Information: in this, guggulu shodhana is done with triphala kwatha
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. patients presenting with the sign and symptoms of Mutrakriccha w.s.r. UTI
2. patients who are giving consent to study. 
 
ExclusionCriteria 
Details  1. patients with STD( sexually transmitted diseases.
2. if congenital anomaly of kidney, ureter, urinary bladder, or urethra.
3. patients with systemic disorders like hypertension , tuberculosis etc.
4. lactating mother or pregnant women. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Subjective parameter- grading will be done with the signs and symptoms of mutrakriccha i.e uti
urine routine & microscopic, Hb , TLC ,DLC, ESR, SGOT/SGPT,S. CREATININ, UREA 
After 21 days intervenetion of gokshuradi guggulu orally and 10 days after stopping the medicine 
 
Secondary Outcome  
Outcome  TimePoints 
Grading will be done with signs & symptoms of mutrakriccha
urine routine & microscopic
Hb
TLC
DLC
ESR
SGOT SGPT
SERUM CREATININ
UREA 
After 21 days intervenetion of gokshuradi guggulu orally & 10 days after stopping the medicine 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   in this trial we are selecting patients of urinary tract infection separately in two groups ( on the basis of medicine prepared with two different methods ) in which we will do interventional study with Gokshuradi Guggulu ( prepared with two different methods ) administered to the patients in the form of tablets with dose of 2 tablets of 500 mg TDS. Assessment will be done on the subjective and objective parameters.
route of administration- oral
follow up on day 10 while taking medicine. 
 
Close